Literature DB >> 1974733

Antiinflammatory effects of various drugs on acetic acid induced colitis in the rat.

L R Fitzpatrick1, J S Bostwick, M Renzetti, R G Pendleton, D L Decktor.   

Abstract

The efficacy of various drugs used to treat ulcerative colitis, (sulfasalazine, 5-aminosalicylate, hydrocortisone) was investigated in a model of acetic acid-induced colitis in the rat. Subsequently, we tested the ability of antioxidant/5-lipoxygenase inhibitors (gossypol and nordihydroguiaretic acid [NDGA]) and a cyclooxygenase inhibitor (indomethacin) to attenuate the macroscopic colonic damage and/or neutrophil influx (myeloperoxidase activity [MPO]) associated with this model of colitis. Oral pretreatment with either sulfasalazine, gossypol, or NDGA significantly decreased colonic MPO activity induced by acetic acid. Intrarectal administration of such drugs resulted in an even larger reduction of the colonic inflammation, with gossypol being the most potent compound. Oral or intrarectal administration of corticosteroids (dexamethasone, hydrocortisone) also attenuated the parameters of acetic acid induced colitis. In contrast, pretreatment with indomethacin was ineffective, or when administered daily after colitis induction, indomethacin actually increased colonic neutrophil influx significantly. Our data suggest that both the route of drug administration and dosing regimen employed affect the antiinflammatory potency and/or efficacy of compounds on colitis induced by acetic acid in the rat. Drugs which were effective against this colitis may act by scavenging of oxygen derived free radicals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974733     DOI: 10.1007/bf01966304

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  29 in total

1.  A new approach to anti-inflammatory drugs.

Authors:  G A Higgs; R J Flower; J R Vane
Journal:  Biochem Pharmacol       Date:  1979-06-15       Impact factor: 5.858

2.  Metabolic fate of gossypol: the metabolism of 14C-gossypol in rats.

Authors:  M B Abou-Donia; C M Lyman; J W Dieckert
Journal:  Lipids       Date:  1970-11       Impact factor: 1.880

3.  A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.

Authors:  Y Ozaki; T Ohashi; Y Niwa
Journal:  Biochem Pharmacol       Date:  1986-10-15       Impact factor: 5.858

4.  Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

Authors:  J L Wallace; W K MacNaughton; G P Morris; P L Beck
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

5.  The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat.

Authors:  N K Boughton-Smith; J L Wallace; G P Morris; B J Whittle
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

6.  Experimental production of diffuse colitis in rats.

Authors:  B R MacPherson; C J Pfeiffer
Journal:  Digestion       Date:  1978       Impact factor: 3.216

7.  Time courses of the anti-anaphylactic and anti-inflammatory effects of dexamethasone in the rat and mouse.

Authors:  M K Church; P Miller
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

8.  The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger.

Authors:  I Ahnfelt-Rønne; O H Nielsen
Journal:  Agents Actions       Date:  1987-06

9.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

Review 10.  Role of eicosanoids in human and experimental colitis.

Authors:  R Schumert; J Towner; R D Zipser
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

View more
  12 in total

1.  Anti-inflammatory drugs and endothelial cell adhesion molecule expression in murine vascular beds.

Authors:  N Mori; Y Horie; M E Gerritsen; D C Anderson; D N Granger
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

2.  Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats.

Authors:  S Choudhary; A Keshavarzian; S Yong; M Wade; S Bocckino; B J Day; A Banan
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

3.  Phospholipase A2 secretion during intestinal graft ischemia.

Authors:  R E Sonnino; L Pigatt; A Schrama; S Burchett; R Franson
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

4.  In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.

Authors:  Sujata P Sawarkar; S G Deshpande; A N Bajaj; V S Nikam
Journal:  AAPS PharmSciTech       Date:  2015-05-28       Impact factor: 3.246

5.  Participation of corticosteroids and effects of indomethacin on the acute inflammatory response of rats fed n-6 or n-3 polyunsaturated fatty acid-rich diets.

Authors:  Marta Wohlers; Claudia M O Nascimento; Roberta A N Xavier; Eliane B Ribeiro; Vera L F Silveira
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

6.  Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin.

Authors:  S N Murthy; H S Cooper; H Shim; R S Shah; S A Ibrahim; D J Sedergran
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

7.  Role of neutrophils in acetic acid-induced colitis in rats.

Authors:  T Yamada; B J Zimmerman; R D Specian; M B Grisham
Journal:  Inflammation       Date:  1991-10       Impact factor: 4.092

8.  Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228: effects on acute colonic inflammation and hepatic function in rodents.

Authors:  D J Fretland; C P Anglin; D Widomski; D A Baron; T Maziasz; P F Smith
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

9.  Induction of neutrophil Mac-1 integrin expression and superoxide production by the medicinal plant extract gossypol.

Authors:  P Benhaim; S J Mathes; T K Hunt; H Scheuenstuhl; C C Benz
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

10.  Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats.

Authors:  B Zingarelli; F Squadrito; P Graziani; R Camerini; A P Caputi
Journal:  Agents Actions       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.